The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

More than half a million people previously diagnosed with HIV have started on HIV treatment since the end of February, the ...

Johannesberg, South Africa | THE INDEPENDENT | Food and Drug Administration (FDA) approval of injectable lenacapavir (LEN) ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

Weeks later, thousands of health workers are unemployed, HIV services are collapsing and the government hasn’t filled the gap ...

Four decades ago, hardly anyone in South Africa had HIV. Today, roughly one in eight people here are living with the virus.

Researchers at the University of Liverpool have indicated that this HIV prevention drug could be manufactured and rolled out at around $40 per person per year.

South Africa’s leadership of the G20 this year is critical for global public health, as it works to tackle the inequalities ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The health crisis has spilled into South Africa’s universities and research hubs. Institutions that once hosted major NIH- ...

More than half a million previously diagnosed people with HIV have been started on HIV treatment since the end of February, ...